Crossmark

Immunomodulators in patients receiving extracorporeal membrane oxygenation for COVID-19: a propensity-score adjusted analysis of the ELSO registry

Crossref DOI link: https://doi.org/10.1186/s13613-024-01368-1

Published Print: 2024

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Ling, Ryan Ruiyang https://orcid.org/0000-0002-8335-7640
Ramanathan, Kollengode https://orcid.org/0000-0003-1822-9455
Shen, Liang https://orcid.org/0000-0001-7976-668X
Barbaro, Ryan P. https://orcid.org/0000-0002-3645-0359
Shekar, Kiran https://orcid.org/0000-0002-1239-7514
Brodie, Daniel https://orcid.org/0000-0002-0813-3145
MacLaren, Graeme https://orcid.org/0000-0002-1307-4274
License Information

Text and Data Mining valid from 2024-01-01

Text and Data Mining valid from 2024-01-01

Version of Record valid from 2025-11-19
More Information

This article is maintained by: Elsevier

Article Title: Immunomodulators in patients receiving extracorporeal membrane oxygenation for COVID-19: a propensity-score adjusted analysis of the ELSO registry

Journal Title: Annals of Intensive Care

CrossRef DOI link to publisher maintained version: https://doi.org/10.1186/s13613-024-01368-1

Content Type: article

Copyright: Copyright © 2024 The Author(s) 2024. Published by Elsevier Masson SAS